Financial results for the period ended March 31, 2026
As filed · Sanofi India Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
EarningsNotablemateriality 72 out of 100
What happened
FactSanofi India Limited's Board of Directors approved the unaudited financial results for the quarter ended 31st March 2026 during their meeting on 28th April 2026. The tenure of Independent Directors Mr. Aditya Narayan and Mrs. Usha Thorat will conclude on 29th April 2026, and Mr. Rahul Bhatnagar has been appointed as the Chairman of the Board effective 30th April 2026. The financial results and Limited Review Report will be available on the company's website and published in…
Why it matters
CapitSignal interpretationReported results are the point at which prior management commitments become checkable against audited or reviewed numbers.
Watch next
Fact- Margin trend against the prior period
- Cash from operations against reported profit
- Whether prior guidance is reaffirmed
Evidence
How CapitSignal classified this
- Reasoning:
- RESULTS base 68; +4 corroborating keywords; matched on subject
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 90%